Searched for
WOCKHARDT FINANCIAL PERFORMANCE
Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...- Aegis Logistics shares rally 4% as Q4 profit rises 45% YoY; Board recommends dividendAegis Logistics shares rose sharply after the company reported a 45% year-on-year rise in Q4 FY26 consolidated net profit to Rs 413 crore, ...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Geopolitical tensions keep markets nervous despite strong earnings: Dipan MehtaGeopolitical tensions, particularly the Iran crisis, are overshadowing strong corporate earnings, according to Dipan Mehta. While India Inc...
- Smallcap winners! Wockhardt, Tata Tech, CAMS, other stocks rally up to 11% despite overall market weaknessSmallcap stocks outperformed on Tuesday despite weak broader markets, with Wockhardt, Tata Tech and CAMS gaining up to 11% on strong Q4 ear...
- Wockhardt shares jump 9% after strong Q4 turnaround, robust FY26 growthWockhardt shares saw a significant jump on Tuesday. The pharmaceutical company reported a strong turnaround in its March quarter performanc...
- Wockhardt Q2 Results: Co swings to profit at Rs 82 croreDrug firm Wockhardt on Monday reported a consolidated profit after tax of Rs 82 crore for the second quarter ended September 30, 2025.
- Wockhardt eyes USD 7 billion market opportunity for antibiotic Zaynich in US, EuropeWockhardt's new antibiotic, Zaynich, targeting gram-negative infections, anticipates a significant USD 7 billion market in the US and Europ...
- Board Meetings Today: Wockhardt, Piramal Enterprises, Sonata Software, and Godrej PropertiesMotilal Oswal Financial Services, Godrej Agro and Subex are among companies which will announce March quarter earnings today.
- Board Meetings Today: HDFC, DRL, InterGlobe Aviation, Wockhardt and United SpiritsIt makes sense to have a look at the corporate agendas for the day’s as announced to the stock exchanges.
- Wockhardt Q4 net loss narrows to Rs 155 croreThe company had posted a net loss of Rs 174.72 crore last year.
- Dr Reddy's third quarter net profit rises by 70%Dr Reddy's Laboratories capitalised on the regulatory troubles of Indian rivals to post its highest quarterly income and operating profit d...
- Wockhardt clears the debt mess, posts 95% YoY growth in Q1The company's consolidated revenues grew by 35% at Rs 1426 cr as against Rs 1053 cr last year, during the same quarter.
- Wockhardt Q1 net profit almost doubles at Rs 378 crPharma firm Wockhardt today reported 94.87 per cent rise in consolidated net profit at Rs 377.97 crore for the first quarter.
- Hard work pays off for Wockhardt: Habil Khorakiwala, Chairman, WockhardtWockhardt has about 70% of its sales accruing from overseas, mostly the US. Hedging is par for the course for companies with forex exposure.
- Wockhardt: Will investors forgive the company?Forget its financial and legal woes, Habil Khorakiwala wants the world to notice that Wockhardt is on the road to recovery.
- Investors unwilling to forgive Wockhardt, promoter for failingsForget its financial and legal woes, Habil Khorakiwala wants the world to notice that Wockhardt is on the road to recovery.
- Sun Pharma and Wockhardt not safe bets: Ashish MaheshwariThere will be a slight blow for Wockhardt stock price and this may come down to 200-215 levels.
- Banks may buy FCCBs of WockhardtIndian banks are likely to buy Wockhardt's FCCBs from foreign investors, as part of the drug major’s corporate debt restructuring (CDR) pro...
- Pricing pressure in Europe, interest costs remain a worry for WockhardtWockhardt, India’s seventh-largest pharma company by revenues, has lately been facing investor concern on account of high interest costs, F...
Load More
